News & Events about Treace Medical Concepts Inc.
Treace Medical Concepts, Inc. (NASDAQ:TMCI Get Rating) Director F Barry Bays sold 48,503 shares of the companys stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $26.51, for a total transaction of $1,285,814.53. Following the completion of the ...
Treace Medical Concepts, Inc. (NASDAQ:TMCI Get Rating) Director James T. Treace sold 40,000 shares of the stock in a transaction that occurred on Friday, April 28th. The shares were sold at an average price of $25.01, for a total transaction of $1,000,400.00. Following the sale, the director...
TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson...
TREACE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options TREACE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered...
TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson...